Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| GDC-0834 | C33H36N6O3S | 1133432-49-1 | Details |
| Taurocholic acid sodium salt hydrate；Taurocholic Acid sodium hydrate;Sodium taurocholate hydrate | C26H46NNaO8S | 345909-26-4 | Details |
| GDP-?α-D-?mannose disodium | C16H23N5Na2O16P2 | 148296-46-2 | Details |
| GDP366 | C20H17N5OS | 501698-03-9 | Details |
| Pictilisib dimethanesulfonate；GDC-0941 2 MeSO3H salt;GDC-0941 dimethanesulfonate | C24H30N7O6S3 | 957054-33-0 | Details |
| GDC-0927；SRN-927 | C28H28FNO4 | 1642297-01-5 | Details |
| Genz-123346 | C52H82N4O14 | 943344-58-9 | Details |
| Gemcabene calcium；PD-72953 calcium | C16H32CaO5 | 209789-08-2 | Details |
| Salbutamol；AH-3365;Albuterol | C13H21NO3 | 18559-94-9 | Details |
| Gefitinib-d8；ZD1839 D8;Gefitinib D8 | C22H24ClFN4O3 | 857091-32-8 | Details |
| Gemfibrozil 1-O-β-glucuronide | C21H30O9 | 91683-38-4 | Details |
| Gemcabene；PD-72953 | C16H30O5 | 183293-82-5 | Details |
| Gemilukast；ONO-6950 | C36H37F2NO5 | 1232861-58-3 | Details |
| Gefitinib N-oxide | C22H24ClFN4O4 | 847949-51-3 | Details |
| Ginsenoside Ra3 | C59H100O27 | 90985-77-6 | Details |
| GKA50 | C26H28N2O6 | 851884-87-2 | Details |
| Gepotidacin；GSK2140944 | C24H28N6O3 | 1075236-89-3 | Details |
| GGTI-2418 | C23H31N5O4 | 501010-06-6 | Details |
| GFB-8438 | C16H14ClF3N4O2 | 2304549-73-1 | Details |
| GLPG0492 (R enantiomer)；GLPG0492 R enantiomer | C19H14F3N3O3 | 1215085-93-0 | Details |
| GET73；GET 73;Gamma hydroxybutyric acid analogue | C13H16F3NO2 | 202402-01-5 | Details |
| GLPG0492 | C19H14F3N3O3 | 1215085-92-9 | Details |
| Doxycycline hydrochloride；Hyclate;Vibramycin;Doxylin | C22H25ClN2O8 | 10592-13-9 | Details |
| Gln-AMS | C15H22N8O8S | 209543-57-7 | Details |
| Gisadenafil besylate；UK 369003-26 | C29H39N7O8S2 | 334827-98-4 | Details |
| GGTI298 | C27H33N3O3S | 180977-44-0 | Details |
| Germacrene D | C15H24 | 23986-74-5 | Details |
| Giredestrant；GDC-9545 | C27H31F5N4O | 1953133-47-5 | Details |
| GENZ-882706；RA03546849 | C26H25N5O3 | 2070864-35-4 | Details |
| GF 15 | C23H21ClO6 | 888042-13-5 | Details |
| GLUT4 activator 1 | C23H21FN4O3S | 2253733-37-6 | Details |
| GLP-26 | C19H17F2N3O3 | 2133017-36-2 | Details |
| Glucagon receptor antagonists-3 | C22H30FNO2 | 202917-17-7 | Details |
| Glyoxalase I inhibitor free base | C21H29BrN4O8S | 174568-92-4 | Details |
| Antibacterial compound 2 | C22H30FN5O6 | 170104-58-2 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| TT-OAD2 free base | C50H47Cl2N3O6 | 1246826-07-2 | Details |
| Glycosidase-IN-2 | C13H23NO5 | 476310-39-1 | Details |
| Glucagon receptor antagonists-1 | C29H34FNO2 | 503559-84-0 | Details |
| Glucocorticoid receptor agonist | C20H20F4N2O2 | 1245526-82-2 | Details |
| Gly-β-MCA | C26H43NO6 | 66225-78-3 | Details |
| Glutaminyl Cyclase Inhibitor 3 | C24H32N6O2S | 2092921-50-9 | Details |
| GLP-1 receptor agonist 1 | C48H48F2N10O5 | 2212020-52-3 | Details |
| GLP-1 receptor agonist 4 | C51H44Cl2N4O6 | 1187061-62-6 | Details |
| Glucagon receptor antagonists-2 | C22H30FNO2 | 202917-18-8 | Details |
| Glutaminyl Cyclase Inhibitor 1 | C21H24FN3O2 | 2110449-60-8 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| Glycolic acid oxidase inhibitor 1 | C16H10BrNO3 | 77529-42-1 | Details |
| O6BTG-octylglucoside；Glucose-conjugated MGMT inhibitor | C24H34BrN5O7S | 382607-78-5 | Details |
| Glyco-Obeticholic acid | C28H47NO5 | 863239-60-5 | Details |
| Glutaminyl Cyclase Inhibitor 4 | C22H33N5O3 | 2376329-36-9 | Details |
| Glyoxalase I inhibitor | C21H30BrClN4O8S | 221174-33-0 | Details |
| Carbenicillin disodium；Sodium carbenicillin;BRL-2064 | C17H19N2NaO6S | 4800-94-6 | Details |
| Glutaminase-IN-1；CB839 derivative | C26H24F3N7O3Se | 2247127-79-1 | Details |
| IPN60090；GLS1-IN-1 | C24H27F3N8O3 | 1853164-83-6 | Details |
| Glucagon receptor antagonists-5 | C30H29ClF3N3O3 | 2200274-63-9 | Details |
| Clindamycin phosphate；Clindamycin 2-phosphate;U-28508;Clindamycin 2-dihydrogen phosphate;NSC 618653 | C18H34ClN2O8PS | 24729-96-2 | Details |
| Glutaminyl Cyclase Inhibitor 2 | C19H20FN3 | 1884546-29-5 | Details |
| GLP-1 receptor agonist 2 | C30H31ClFN5O4 | 2230197-64-3 | Details |
| Fenbendazole；Fenbendazol;Phenbendasol;Panacur | C15H13N3O2S | 43210-67-9 | Details |
| GLP-1 receptor agonist 3 | C31H30FN5O4 | 2230200-09-4 | Details |
| Glycosidase-IN-1 | C13H23NO5 | 170376-12-2 | Details |
| GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
| Golotimod；SCV 07;Gamma-D-glutamyl-L-tryptophan | C16H19N3O5 | 229305-39-9 | Details |
| GlyRS-IN-1 | C12H17N7O7S | 112921-11-6 | Details |
| GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| Lenacapavir；GS-6207 | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| GPR120 modulator 2 | C20H18ClNO3S | 1050506-87-0 | Details |
| GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
| GPI-1046 | C20H28N2O4 | 186452-09-5 | Details |
| Gosogliptin；PF-00734200;PF-734200 | C17H24F2N6O | 869490-23-3 | Details |
| GNF179 (Metabolite)；GNF179 Metabolite | C14H16FN3 | 1310455-86-7 | Details |
| GNF-6231 | C24H25FN6O2 | 1243245-18-2 | Details |
| GNE 220 | C25H26N8 | 1199590-75-4 | Details |
| GNF362 | C22H21F3N6 | 1003019-41-7 | Details |
| Lidocaine hydrochloride；Xyloneural;Lidocaine HCL;Lidothesin;Lignocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
| GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
| GRL0617 | C20H20N2O | 1093070-16-6 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| Lidocaine Hydrochloride hydrate | C14H25ClN2O2 | 6108-05-0 | Details |
| GPR84 antagonist 8 | C23H23N3O5 | 1445846-30-9 | Details |
| GNF4877 | C25H27FN6O4 | 2041073-22-5 | Details |
| GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
| GPR4 antagonist 1 | C27H37N5 | 1197879-16-5 | Details |
| Nifedipine；Procardia XL;Procardia;BAY-a-1040;Adalat | C17H18N2O6 | 21829-25-4 | Details |
| GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
| NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
| Chlorhexidine dihydrochloride；Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | C22H32Cl4N10 | 3697-42-5 | Details |
| GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
| GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
| Diminazene Aceturate | C22H29N9O6 | 908-54-3 | Details |
| GR 103691 | C30H35N3O3 | 162408-66-4 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
| GSK-2793660 | C20H27N3O3 | 1613458-70-0 | Details |
| Product Total： Product Page： | ||||
| 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 | ||||